20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T16550 | PKR-IN-C16 | Others | |
PKR-IN-C16 is a specific protein kinase (PKR) inhibitor. PKR-IN-C16 is able to inhibit the autophosphorylation of PKR and unlock the translation blockade induced by PKR in primary neuronal cultures.PKR-IN-C16 binds the A... | |||
T12499 | PKR-IN-2 | PKM | |
PKR-IN-2 is a activator of pyruvate kinase (PKR). | |||
T24647 | PKR-IN-C51 | PKRINC51,PKR IN C51,PKR-inhibitor-C51,PKR inhibitor C51 | |
PKR-IN-C51 is an inhibitor of protein kinase R. It acts by correcting the aberrant splicing of MBNL1-dependent pre-mRNAs in DM1 cells without affecting the splicing pattern in normal non-DM1 cells. | |||
T4223 | Mitapivat | PKR-IN-1 | PKM |
Mitapivat (PKR-IN-1), also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency. | |||
T12498 | PKR activator 2 | Others | |
PKR activator 2 is a potent activator of pyruvate kinase-R (PKR). | |||
T12497 | PKR activator 1 | Others | |
PKR activator 1 is a potent activator of pyruvate kinase-R (PKR). | |||
T75132 | PKR activator 4 | ||
PKR activator 4 (example 7A), a potent activator of pyruvate kinase R (PKR), holds promise for blood disorder research [1]. | |||
T2614 | GSK2606414 | Apoptosis , PERK , Autophagy | |
GSK2606414 is an oral-available and specific PERK inhibitor (IC50=0.4 nM). | |||
T2654 | GSK2656157 | Apoptosis , PERK , Autophagy | |
GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases. | |||
T21976 | ONO-8130 | Prostaglandin Receptor | |
ONO-8130 is an orally available antagonist of EP1 receptor. | |||
T22436 | Takeda-6d | VEGFR | |
Takeda-6d, a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits B-RAF and VEGFR2 with IC50 of 7.0nM and 2.2nM. | |||
T6183 | ISRIB (trans-isomer) | ISRIB,ISRIB trans-isomer,trans-isomer,trans-ISRIB | Apoptosis , PERK , Autophagy |
ISRIB (trans-isomer) (ISRIB trans-isomer), the trans-isomer of ISRIB, is a effective and specific PERK inhibitor (IC50: 5 nM). | |||
T63446 | PKRA83 | ||
PKRA83 is a potent prokineticin (PK2) antagonist that crosses the blood-brain barrier and competes for PK2 binding to its receptors PKR1 and PKR2. PKRA83 effectively inhibits PK2 receptors and acts on PKR1 (IC50: 5.0 nM)... | |||
T81445 | PKRA83 hydrochloride hydrate | PKRA7 hydrochloride hydrate | |
PKRA83 hydrochloride hydrate, also known as PKRA7, is a potent prokineticin (PK2) antagonist that competes with PK2 for binding to its receptors, PKR1 and PKR2. It exhibits high inhibitory affinity with IC50 values of 5.... | |||
T7214 | TEPP-46 | ML265 | PKM |
TEPP-46 (ML265) is a potent PKM2 activator (AC50 : 92 nM) showing little or no effect on PKM1, PKL and PKR,induces tetramerization and reduces tumor formation and size in a mouse xenograft model. . | |||
T19836 | 2-Aminopurine | DNA/RNA Synthesis , PKA | |
2-Aminopurine is a double-stranded RNA-dependent protein kinase, protein kinase R (PKR) inhibitor. | |||
T71825 | BEPP monohydrochloride | ||
BEPP monohydrochloride is a double-strand RNA-dependent protein kinase (PKR) activator. | |||
T26398 | 7DG | 7-DG | |
7DG is a selective inhibitor of protein kinase R (PKR). | |||
T23813 | Bozepinib | ||
Bozepinib is an antitumor compound that acts by inducing PKR-mediated apoptosis and synergizing with IFN. | |||
T39753 | Etavopivat | FT-4202 | |
Etavopivat is a powerful, specific, orally bioavailable activator of pyruvate kinase (PKR) in red blood cells (RBCs). It exhibits potent properties against sickling. |